Login to Your Account



Washington Roundup


Tuesday, October 16, 2012
The SEC has begun administrative proceedings against EPIX Pharmaceuticals Inc. and GlycoGenesys Inc. The agency cited Lexington, Mass.-based EPIX for being delinquent in its periodic filings since March 31, 2009.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription